AlphaMadera's AlphaVal page computes The Southern Company's fair value using a multi-method blend (DCF, comparable-multiples, and Graham-style intrinsic value), then compares it to the current market price to flag SOMN as undervalued, fairly valued, or overvalued.

What is The Southern Company's fair value?

Fair value for SOMN is a model output combining discounted cash flow projections, peer-group multiples, and a Graham number floor. The live AlphaVal page shows the blended fair value alongside each method's individual estimate.

How does AlphaMadera value SOMN?

AlphaVal uses three primary techniques: a five-year discounted-cash-flow projection with terminal multiple, peer-group multiple analysis (P/E, EV/EBITDA, P/S), and Graham's defensive-investor intrinsic-value formula. Inputs come from SOMN's most recent reported fundamentals.

SOMN - The Southern Company

Price: -- --

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 85% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Fair Value Moderate

Trading 20.2% below fair value

Current Price $50.32

Bear Case $55.20 9.7% upside ($55.20 - $50.32) / $50.32 = 9.7% $3.94 × 14x P/E

Fair Value $63.08 25.4% upside ($63.08 - $50.32) / $50.32 = 25.4% $3.94 × 16x P/E

Bull Case $70.97 41.0% upside ($70.97 - $50.32) / $50.32 = 41.0% $3.94 × 18x P/E

Adjust Assumptions

P/E Multiple

16.0x

Adjusted EPS

3.94$

Key Value Driver

Normalized P/E multiple (16x base case)

Implied Market Multiple 12.8x

Plain-Language Summary

Applying a 16x P/E to adjusted EPS of $3.94, the base-case value is $63.08 per share.

Key Risks

Growth DCF inappropriate — terminal value assumptions dominate
EV/EBITDA misleading for regulated businesses where capex is mandated
Regulatory risk is a fat tail not visible in normal multiples